Literature DB >> 10688204

The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences.

J Parkhill1, B W Wren, K Mungall, J M Ketley, C Churcher, D Basham, T Chillingworth, R M Davies, T Feltwell, S Holroyd, K Jagels, A V Karlyshev, S Moule, M J Pallen, C W Penn, M A Quail, M A Rajandream, K M Rutherford, A H van Vliet, S Whitehead, B G Barrell.   

Abstract

Campylobacter jejuni, from the delta-epsilon group of proteobacteria, is a microaerophilic, Gram-negative, flagellate, spiral bacterium-properties it shares with the related gastric pathogen Helicobacter pylori. It is the leading cause of bacterial food-borne diarrhoeal disease throughout the world. In addition, infection with C. jejuni is the most frequent antecedent to a form of neuromuscular paralysis known as Guillain-Barré syndrome. Here we report the genome sequence of C. jejuni NCTC11168. C. jejuni has a circular chromosome of 1,641,481 base pairs (30.6% G+C) which is predicted to encode 1,654 proteins and 54 stable RNA species. The genome is unusual in that there are virtually no insertion sequences or phage-associated sequences and very few repeat sequences. One of the most striking findings in the genome was the presence of hypervariable sequences. These short homopolymeric runs of nucleotides were commonly found in genes encoding the biosynthesis or modification of surface structures, or in closely linked genes of unknown function. The apparently high rate of variation of these homopolymeric tracts may be important in the survival strategy of C. jejuni.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688204     DOI: 10.1038/35001088

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  768 in total

1.  Macrolide resistance in Campylobacter coli of animal origin in Denmark.

Authors:  L B Jensen; F M Aarestrup
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  Essential thioredoxin-dependent peroxiredoxin system from Helicobacter pylori: genetic and kinetic characterization.

Authors:  L M Baker; A Raudonikiene; P S Hoffman; L B Poole
Journal:  J Bacteriol       Date:  2001-03       Impact factor: 3.490

3.  An Eulerian path approach to DNA fragment assembly.

Authors:  P A Pevzner; H Tang; M S Waterman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

4.  Evolutionary analysis by whole-genome comparisons.

Authors:  Arvind K Bansal; Terrance E Meyer
Journal:  J Bacteriol       Date:  2002-04       Impact factor: 3.490

Review 5.  Alpha-crystallin-type heat shock proteins: socializing minichaperones in the context of a multichaperone network.

Authors:  Franz Narberhaus
Journal:  Microbiol Mol Biol Rev       Date:  2002-03       Impact factor: 11.056

6.  Comparing function and structure between entire proteomes.

Authors:  J Liu; B Rost
Journal:  Protein Sci       Date:  2001-10       Impact factor: 6.725

Review 7.  Lactate stimulation of gonococcal metabolism in media containing glucose: mechanism, impact on pathogenicity, and wider implications for other pathogens.

Authors:  H Smith; E A Yates; J A Cole; N J Parsons
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

8.  Comparative fingerprinting analysis of Campylobacter jejuni subsp. jejuni strains by amplified-fragment length polymorphism genotyping.

Authors:  B A Lindstedt; E Heir; T Vardund; K K Melby; G Kapperud
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

9.  tRNomics: analysis of tRNA genes from 50 genomes of Eukarya, Archaea, and Bacteria reveals anticodon-sparing strategies and domain-specific features.

Authors:  Christian Marck; Henri Grosjean
Journal:  RNA       Date:  2002-10       Impact factor: 4.942

10.  The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.

Authors:  Peggy C R Godschalk; Astrid P Heikema; Michel Gilbert; Tomoko Komagamine; C Wim Ang; Jobine Glerum; Denis Brochu; Jianjun Li; Nobuhiro Yuki; Bart C Jacobs; Alex van Belkum; Hubert P Endtz
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.